• Why this expert says the ‘do nothing’ approach to retirement planning is not good advice amid market uncertainty

  • Pelosi against extra jobless benefits temporary extension

  • The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings

  • ‘Capital war’ possible if US bans investment in China or withholds bond payments: Ray Dalio